Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - betahistine dihydrochloride, quantity: 16 mg - tablet, uncoated - excipient ingredients: colloidal anhydrous silica; microcrystalline cellulose; mannitol; citric acid monohydrate; purified talc - meniere's syndrome as defined by the following core symptoms: - vertigo (with nausea/vomiting): - hearing loss (hardness of hearing): - tinnitus.

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - betahistine dihydrochloride, quantity: 16 mg - tablet - excipient ingredients: lactose monohydrate; maize starch; microcrystalline cellulose; citric acid; povidone; crospovidone; hydrogenated vegetable oil - meniere's syndrome as defined by the following core symptoms: vertigo (with nausea / vomiting), hearing loss (hardness of hearing), tinnitus.

Australia - English - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - betahistine dihydrochloride, quantity: 16 mg - tablet, uncoated - excipient ingredients: citric acid; microcrystalline cellulose; mannitol; colloidal anhydrous silica; purified talc - meniere's syndrome as defined by the following core symptoms: vertigo (with nausea/vomiting), hearing loss (hardness of hearing) and tinnitus.

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - betahistine dihydrochloride, quantity: 16 mg - tablet - excipient ingredients: lactose monohydrate; maize starch; microcrystalline cellulose; citric acid; povidone; crospovidone; hydrogenated vegetable oil - meniere's syndrome as defined by the following core symptoms: vertigo (with nausea / vomiting), hearing loss (hardness of hearing), tinnitus.

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - betahistine dihydrochloride -

Israel - English - Ministry of Health

abic marketing ltd, israel - betahistine dihydrochloride - tablets - betahistine dihydrochloride 16 mg - betahistine - betahistine - meniere's syndrom. symptomatic treatment of peripheral vertigo.

Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - betahistine dihydrochloride, quantity: 16 mg - tablet - excipient ingredients: crospovidone; lactose monohydrate; povidone; stearic acid; colloidal anhydrous silica; microcrystalline cellulose - meniere?s syndrome as defined by the following core symptoms: ,- vertigo (with nausea/vomiting) ,- hearing loss (hardness of hearing) ,- tinnitus

Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - betahistine dihydrochloride, quantity: 8 mg - tablet - excipient ingredients: stearic acid; crospovidone; colloidal anhydrous silica; povidone; lactose monohydrate; microcrystalline cellulose - meniere?s syndrome as defined by the following core symptoms: ,- vertigo (with nausea/vomiting) ,- hearing loss (hardness of hearing) ,- tinnitus

Malta - English - Medicines Authority

actavis group h.f. reykjavikurvegur 78, 220 hafnarfjörður, iceland - betahistine dihydrochloride - tablet - betahistine dihydrochloride 8 mg - other nervous system drugs

Malta - English - Medicines Authority

actavis group h.f. reykjavikurvegur 78, 220 hafnarfjörður, iceland - betahistine dihydrochloride - tablet - betahistine dihydrochloride 16 mg - other nervous system drugs